Synthesis & Anticancer Evaluation of New Substituted 2-(3,4- Dimethoxyphenyl)benzazoles

Author(s): Cigdem Karaaslan, Yalcin Duydu, Aylin Ustundag, Can O. Yalcin, Banu Kaskatepe, Hakan Goker*.

Journal Name: Medicinal Chemistry

Volume 15 , Issue 3 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: The benzazole nucleus is found in many promising small molecules such as anticancer and antibacterial agents. Bendamustine (Alkylating agent), Nocodazole (Mitotic inhibitor), Veliparib (PARP inhibitor), and Glasdegib (SMO inhibitor) are being clinically used as anticancer therapeutic which bear benzimidazole moiety. Based on the principle of bioisosterism, in the present work, 23 compounds belonging to 2-(3,4-dimethoxyphenyl)benzazoles and imidazopyridine series were synthesized and evaluated for their anticancer and antimicrobial activities.

Objective: A series of new 2-(3,4-dimethoxyphenyl)-1H-benz(or pyrido)azoles were synthesized and evaluated for their anticancer and antimicrobial activities.

Method: N-(5-chloro-2-hdroxyphenyl)-3,4-dimethoxybenzamide 1, was obtained by the amidation of 2-hydroxy-5-chloroaniline with 3,4-dimethoxybenzoic acid by using 1,1'-carbonyldiimidazole. Cyclization of 1 to benzoxazole derivative 2, was achieved by p-toluenesulfonic acid. Other 1H-benz(or pyrido)azoles were prepared by the reaction between 2-aminothiophenol, ophenylenediamine, o-pyridinediamine with sodium metabisulfite adduct of 3,4-dimethoxybenzaldehyde. The NMR assignments of the dimethoxy groups were established by the NOESY spectra.

Results: Compound 12, bearing two chlorine atoms at the 5(4) and 7(6) positions of the benzene moiety of benzimidazole was found the most potent analogue against A549 cells with the GI50 value of 1.5 μg/mL. Moreover, 24 showed remarkable cell growth inhibition against MCF-7 and HeLa cells with the GI50 values of 7 and 5.5 μg/mL, respectively. The synthesized compounds have no important antibacterial and antifungal activities.

Conclusion: It could be concluded that the introduction of di-chloro atoms at the phenyl ring of 2-(3,4-dimethoxyphenyl)-1H-benzimidazoles increases significant cytotoxicity to selected human tumor cell lines in comparison to other all benzazoles synthesized. Unsubstituted 2-(3,4- dimethoxyphenyl)-imidazopyridines also gave good inhibitory profile against A549 and HeLa cells.

Keywords: 3, 4-Dimethoxyphenyl, NOESY, 1H-benzimidazole, imidazopyridine, benzoxazole, benzothiazole.

[1]
Hoelder, S.; Clarke, P.A.; Workman, P. Discovery of small molecule cancer drugs: Successes, challenges and opportunities. Mol. Oncol., 2012, 6, 155-176.
[2]
Hutchinson, I.; Chua, M.S.; Browne, H.L.; Trapani, V.; Bradshaw, T.D.; Westwell, A.D.; Stevens, M.F.G. Antitumor benzothiazoles. 14. Synthesis and in vitro biological properties of fluorinated 2-(4-aminophenyl) benzothiazoles. J. Med. Chem., 2001, 44(9), 1446-1455.
[3]
Callero, M.A.; Luzzani, G.A.; De Dios, D.O.; Bradshaw, T.D.; Perez, A.I.L. Biomarkers of sensitivity to potent and selective antitumor 2-(4-amino-3-methylphenyl)-5-fluoro benzothiazole (5F203) in ovarian cancer. J. Cell. Biochem., 2013, 114, 2392-2404.
[4]
Mortimer, C.G.; Wells, G.; Crochard, J.P.; Stone, E.L.; Bradshaw, T.D.; Steven, M.F.G.; Westwel, A.D. Antitumor benzothiazoles. 26.1 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selec-tive inhibitory activity against lung, colon and breast cancer cell lines. J. Med. Chem., 2006, 49(1), 179-185.
[5]
Kadri, H.; Matthews, C.S.; Bradshaw, T.D.; Stevens, M.F.G.; Westwell, A.D. Synthesis and antitumour evaluation of novel 2-phenylbenzimidazoles. J. Enzyme Inhib. Med. Chem., 2008, 23(5), 641-647.
[6]
Wu, L.; Yang, S.H.; Xiong, H.; Yang, J.Q.; Guo, J.; Yang, W.C.; Yang, G.F. Nonpeptide-based small-molecule probe for fluorogenic and chromogenic detection of chymotrypsin. Anal. Chem., 2017, 89, 3687-3693.
[7]
Siddiqui, H.; Farooq, R.; Marasini, B.P.; Malik, R.; Syed, N.; Moin, S.T.; Rahman, A.; Choudhary, M.I. Synthesis and in vitro α-chymotrypsin inhibitory activity of 6-chlorobenzimidazole derivatives. Bioorg. Med. Chem., 2016, 24, 3387-3395.
[8]
Ridley, H.F.; Spickett, R.G.W.; Timmis, G.M. A new synthesis of benzimidazoles and aza-analogs. J. Heterocycl. Chem., 1965, 2, 453-456.
[9]
Göker, H.; Karaaslan, C.; Yildiz, S. Potent antifungal and antistaphylococcal 2-anilinobenzimidazoles. Z. Naturforsch. C, 2012, 67, 486-494.
[10]
Göker, H.; Ozden, S.; Yildiz, S.; Boykin, D. Synthesis and potent antibacterial activity against MRSA of some novel 1,2-disubstituted-1H-benzimidazole-N-alkylated-5-carboxamidines. Eur. J. Med. Chem., 2005, 40, 1062-1069.
[11]
Göker, H.; Alp, M.; Yildız, S. Synthesis and potent antimicrobial activity of some novel N-(alkyl)-2-phenyl-1H-benzimidazole-5-carboxamidines. Molecules, 2005, 10, 1377-1386.
[12]
Cavalla, D.J.; Chasin, M.; Hofer, P.; Dolby, L. Novel benzoxazoles., 1996. PCT WO9611917A1
[13]
Ha, Y.M.; Park, J.Y.; Park, Y.J.; Park, D.; Choi, Y.J.; Kim, J.M.; Lee, E.K.; Han, Y.K.; Kim, J.A.; Lee, J.Y.; Moon, H.R.; Chung, H.Y. Syn-thesis and biological activity of hydroxy substituted phenyl- benzo[d]thiazole analogues for antityrosinase activity in B16 cells. Bioorg. Med. Chem. Lett., 2011, 21, 2445-2449.
[14]
Robertson, D.W.; Beedle, E.E.; Krushinski, J.H.; Pollock, G.D.; Wilson, H.; Wyss, V.L.; Hayes, J.S. Structure-activity relationships of arylimidazopyridine cardiotonics: Discovery and inotropic activity of 2-[2-Methoxy-4-(methylsulfiny1) phenyl-1H-imidazo [4,5-c] pyri-dine. J. Med. Chem., 1985, 24, 717-727.
[15]
Taha, M.; Ismail, N.H.; Imran, S.; Ainaa, I.; Selvaraj, M.; Baharudin, M.S.; Ali, M.; Khan, K.M.; Uddin, N. Synthesis of 2-phenyl-1H-imidazo [4,5-b] pyridine as type 2 diabetes inhibitors and molecular docking studies. Med. Chem. Res., 2017, 26(5), 916-928.
[16]
Das, B.; Kanth, B.S.; Reddy, K.R.; Kumar, A.S. Sulfonic acid functionalized silica as an efficient heterogeneous recyclable catalyst for one-pot synthesis of 2-substituted benzimidazoles. J. Heterocycl. Chem., 2008, 45, 1499-1502.
[17]
Gurudatt, D.M.; Mohana, K.N. Synthesis of new benzimidazole derivatives and their corrosion inhibition performance on mild steel in 0.5 M hydrochloric acid. J. Applicab. Chem., 2013, 2(5), 1296-1314.
[18]
Kilcigil, G.; Kus, C.; Ozdamar, E.D.; Eke, B.; Iscan, M. Synthesis and antioxidant capacities of some new benzimidazole derivatives. Arch. Pharm., 2007, 340(11), 607-611.
[19]
Taha, M.; Ismail, N.H.; Imran, S.; Selvaraj, M.; Rashwan, H.; Farhanah, F.U.; Rahim, F.; Kesavanarayanan, K.S.; Ali, M. Synthesis of benzimidazole derivatives as potent B-glucuronidase inhibitors. Bioorg. Chem., 2015, 61, 36-44.
[20]
Navarrete-Vázquez, G.; Moreno-Diaz, H.; Estrada-Soto, S.; Torres-Piedra, M. Microwave-assisted one-pot synthesis of 2-(substitutedphenyl)-1H-benzimidazole derivatives. Synth. Commun., 2007, 37, 2815-2825.
[21]
Göker, H.; Tuncbilek, M.; Suzen, S.; Kus, C.; Altanlar, N. Synthesis and antimicrobial activity of some new 2-Phenyl-N-substituted car-boxamido-1H-benzimidazole derivatives. Arch. Pharm. Pharm. Med. Chem., 2001, 334, 148-152.
[22]
Mukhopadhyay, C.; Tapaswi, P.K. PEG-mediated catalyst-free expeditious synthesis of 2-substituted benzimidazoles and bis-benzimidazoles under solvent-less conditions. Tetrahedron Lett., 2008, 49, 6237-6240.
[23]
Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 1983, 65(1-2), 55-63.
[24]
Kuźma, L.; Wysokińska, H.; Różalski, M.; Krajewska, U.; Kisiel, W. An unusual taxodione derivative from hairy roots of Salvia austriaca. Fitoterapia, 2012, 83(4), 770-773.
[25]
Clinical and Laboratory Standard Institute (CLSI). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard—Ninth Edition M07-A9, Vol. 32, No. 2. 2015.
[26]
Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of yeasts. 3rd ed.; M27-A3, Wayne, PA: CLSI. 2008.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 15
ISSUE: 3
Year: 2019
Page: [287 - 297]
Pages: 11
DOI: 10.2174/1573406414666180711130012
Price: $58

Article Metrics

PDF: 31
HTML: 3